8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
May 1, 2026·SEC
Material company update
Nov 18, 2025·SEC
Scienture Holdings, Inc.(SCNX)Earnings, Financials & Key Ratios
SCNX•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryHealthcare Communications, Workforce and Supply Chain
AboutTRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.Show more
- Revenue$432K+215.9%
- EBITDA-$16M-7.5%
- Net Income-$42M-557.9%
- EPS (Diluted)-2.70-208.9%
- Gross Margin76.8%+1647.6%
- EBITDA Margin-3649.83%+66.0%
- Operating Margin-3763.78%+65.0%
- Net Margin-9618.03%-245.0%
- ROE-0.12%-100.5%
SCNX Key Insights
Scienture Holdings, Inc. (SCNX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading at only 0.0x book value
✗Weaknesses
- ✗Profits declining 74.9% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Sales declining 52.1% over 5 years
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SCNX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SCNX Price & Volume
Scienture Holdings, Inc. (SCNX) stock price & volume — 10-year historical chart
Loading chart...
SCNX Growth Metrics
Scienture Holdings, Inc. (SCNX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-17.38%
5 Years-52.1%
3 Years-65.21%
TTM225.17%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-174.53%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM24.99%
Return on Capital
10 Years-32.43%
5 Years-108.82%
3 Years-125.42%
Last Year-0.04%
SCNX Recent Earnings
Scienture Holdings, Inc. (SCNX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 1/12 qtrs (14%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.08+65.2%
$0.23
Rev
$56,325-86.0%
$400,983
Q2 2026
Mar 24, 2026Metric
Actual
Est
EPS
$1.76-700.0%
$0.22
Rev
$168,699-134.7%
$486,415
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.19
—
Rev
$590,050
—
Q3 2025
Aug 12, 2025Metric
Actual
Est
EPS
$0.48
—
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.08vs $0.23+65.2% | $56,325vs $400,983-86.0% |
| Q2 2026 | Mar 24, 2026 | $1.76vs $0.22-700.0% | $168,699vs $486,415-134.7% |
| Q4 2025 | Nov 12, 2025 | $0.19 | $590,050 |
| Q3 2025 | Aug 12, 2025 | $0.48 | — |
Based on last 12 quarters of dataView full earnings history →
SCNX Peer Comparison
Scienture Holdings, Inc. (SCNX) competitors in Healthcare Communications, Workforce and Supply Chain — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PRAX | 8.15B | 282.31 | -20.94 | -100% | -43.02% | 0.00 | ||
 TARS | 2.72B | 63.16 | -39.72 | 146.71% | -9.02% | -14.19% | 0.27 | |
 NUVL | 9.08B | 123.43 | -21.10 | -42.78% | ||||
 KALA | 79.17M | 3.61 | -1.09 | -13.36% | ||||
 ETON | 889.7M | 32.48 | -191.06 | 104.94% | -1.7% | -5.68% | 1.19 | |
 TLPH | 46.23M | 1.09 | -3.21 | -14253% | -92.98% | 0.38 | ||
 HROW | 1.6B | 42.87 | -306.21 | 36.41% | -5.57% | -33.92% | 4.84 | |
 DERM | 171.19M | 6.22 | -13.23 | 10.2% | -14.82% | -35.57% | 0.00 |
Compare SCNX vs Peers
Scienture Holdings, Inc. (SCNX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SCNX Income Statement
Scienture Holdings, Inc. (SCNX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.93M | 3.83M | 7.44M | 17.12M | 9.89M | 10.25M | 1.36M | 136.64K | 431.61K | 477.68K |
Revenue Growth % | 18.11% | 30.72% | 94.07% | 130.26% | -42.24% | 3.65% | -86.69% | -89.98% | 215.87% | 225.17% |
Cost of Goods Sold | 0 | 449.05K | 2.57M | 11.42M | 5.14M | 4.73M | 1.31M | 130.64K | 100.13K | 561.03K |
COGS % of Revenue | - | 11.72% | 34.5% | 66.67% | 52.01% | 46.15% | 96.41% | 95.61% | 23.2% | - |
Gross Profit | 2.93M▲ 0% | 3.38M▲ 15.4% | 4.87M▲ 44.0% | 5.71M▲ 17.2% | 4.75M▼ 16.8% | 5.52M▲ 16.3% | 49.03K▼ 99.1% | 6K▼ 87.8% | 331.48K▲ 5420.1% | -83.35K▲ 0% |
Gross Margin % | 100% | 88.28% | 65.5% | 33.33% | 47.99% | 53.85% | 3.6% | 4.39% | 76.8% | -17.45% |
Gross Profit Growth % | 18.89% | 15.4% | 43.99% | 17.18% | -16.84% | 16.29% | -99.11% | -87.75% | 5420.1% | - |
Operating Expenses | 2.54M | 3.47M | 4.75M | 8.21M | 10.04M | 8.44M | 4.45M | 14.71M | 16.58M | 15.35M |
OpEx % of Revenue | 86.52% | 90.57% | 63.82% | 47.97% | 101.5% | 82.29% | 325.96% | 10763.1% | 3840.58% | - |
Selling, General & Admin | 1.41M | 3.47M | 4.38M | 7.49M | 7.54M | 6.57M | 4.35M | 12.05M | 14.52M | 2.02B |
SG&A % of Revenue | 47.93% | 90.57% | 58.86% | 43.73% | 76.2% | 64.07% | 318.6% | 8821.54% | 3364.79% | - |
Research & Development | 863.32K | 949.95K | 0 | 662.73K | 899.71K | 993.18K | 0 | 2.24M | 1.96M | 2.18M |
R&D % of Revenue | 29.45% | 24.79% | - | 3.87% | 9.1% | 9.69% | - | 1636.89% | 453.25% | - |
Other Operating Expenses | 267.83K | -949.95K | 368.52K | 63.25K | 1.6M | 875.25K | 100.28K | 416.31K | 97.26K | -447.72K |
Operating Income | 395.1K▲ 0% | -87.62K▼ 122.2% | 125.22K▲ 242.9% | -2.51M▼ 2101.7% | -5.29M▼ 111.1% | -2.92M▲ 44.9% | -4.4M▼ 50.8% | -14.7M▼ 234.4% | -16.24M▼ 10.5% | -15.43M▲ 0% |
Operating Margin % | 13.48% | -2.29% | 1.68% | -14.64% | -53.51% | -28.45% | -322.36% | -10758.7% | -3763.78% | -3230.04% |
Operating Income Growth % | 139.22% | -122.18% | 242.92% | -2101.74% | -111.13% | 44.9% | -50.77% | -234.38% | -10.5% | - |
EBITDA | 446.04K | 66.58K | 219.96K | -2.4M | -5.15M | -2.72M | -3.35M | -14.65M | -15.75M | -14.48M |
EBITDA Margin % | 15.22% | 1.74% | 2.96% | -14.04% | -52.11% | -26.55% | -245.38% | -10719.65% | -3649.83% | -3032.26% |
EBITDA Growth % | 143.66% | -85.07% | 230.37% | -1193.02% | -114.35% | 47.19% | -22.98% | -337.68% | -7.55% | -13.88% |
D&A (Non-Cash Add-back) | 0 | 0 | 94.73K | 102.52K | 138.91K | 194.7K | 1.05M | 53.36K | 491.78K | 944.77K |
EBIT | 446.04K | 66.58K | -231.2K | -2.51M | -5.29M | -2.07M | -7.34M | -17.44M | -39.42M | -40.54M |
Net Interest Income | -157.06K | -57.54K | -53.23K | -29.39K | -23.59K | -315.22K | -1.14M | -1.2M | -3.78M | -3.04M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 20.99K | 4.2K | 135.34K | 302.7K | 410.6K |
Interest Expense | 157.06K | 57.54K | 53.23K | 29.39K | 23.59K | 336.21K | 1.14M | 1.34M | 4.08M | 3.45M |
Other Income/Expense | -106.11K | 96.65K | -409.65K | -29.39K | -23.59K | 512.53K | -4.09M | -4.08M | -27.26M | -28.42M |
Pretax Income | 288.98K▲ 0% | 9.04K▼ 96.9% | -284.43K▼ 3247.0% | -2.54M▼ 791.6% | -5.32M▼ 109.6% | -2.4M▲ 54.8% | -8.48M▼ 252.9% | -18.78M▼ 121.4% | -43.51M▼ 131.7% | -43.85M▲ 0% |
Pretax Margin % | 9.86% | 0.24% | -3.82% | -14.81% | -53.75% | -23.45% | -621.99% | -13743.02% | -10080.22% | -9178.9% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -534.4K | -1.99M | -1.99M |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 2.85% | 4.59% | 4.55% |
Net Income | 288.98K▲ 0% | 9.04K▼ 96.9% | -284.43K▼ 3247.0% | -2.54M▼ 791.6% | -5.32M▼ 109.6% | -3.47M▲ 34.7% | -17.84M▼ 413.9% | 9.07M▲ 150.8% | -41.51M▼ 557.9% | -41.85M▲ 0% |
Net Margin % | 9.86% | 0.24% | -3.82% | -14.81% | -53.75% | -33.87% | -1308.34% | 6634.66% | -9618.03% | -8761.28% |
Net Income Growth % | 110.47% | -96.87% | -3247.02% | -791.63% | -109.61% | 34.68% | -413.91% | 150.81% | -557.9% | -174.53% |
Net Income (Continuing) | 288.98K | 9.04K | -284.43K | -2.54M | -5.32M | -2.4M | -8.48M | -18.24M | -41.51M | -41.85M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -1.51M | -9.36M | 27.31M | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | -420.27K | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.90▲ 0% | 0.02▼ 97.4% | -0.72▼ 3190.1% | -4.94▼ 586.1% | -9.80▼ 98.4% | -6.15▲ 37.2% | -7.49▼ 21.8% | 2.48▲ 133.1% | -2.70▼ 208.9% | -0.10▲ 0% |
EPS Growth % | 111.44% | -97.41% | -3190.13% | -586.11% | -98.38% | 37.24% | -21.79% | 133.11% | -208.87% | 24.99% |
EPS (Basic) | 0.90 | 0.03 | -0.72 | -4.94 | -9.80 | -6.15 | -23.35 | 2.69 | -2.70 | - |
Diluted Shares Outstanding | 378.74K | 388.35K | 395.27K | 513.71K | 542.45K | 564.86K | 2.38M | 3.65M | 153.47M | 406.31M |
Basic Shares Outstanding | 355.06K | 358.38K | 395.27K | 513.71K | 542.45K | 564.86K | 764.06K | 3.38M | 153.47M | 406.31M |
Dividend Payout Ratio | - | - | - | - | - | - | - | 163.9% | - | - |
SCNX Balance Sheet
Scienture Holdings, Inc. (SCNX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 607.48K | 1.47M | 3.8M | 9.22M | 4.37M | 2.09M | 2.75M | 6.31M | 7.92B | 4.77B |
Cash & Short-Term Investments | 183.91K | 869.56K | 2.87M | 5.92M | 3.12M | 1.09M | 314 | 308.1K | 308.1K | 3.54B |
Cash Only | 183.91K | 869.56K | 2.87M | 5.92M | 3.12M | 1.09M | 314 | 308.1K | 308.1K | 3.54B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 319.47K | 433.63K | 792.05K | 1.89M | 978.97K | 629.92K | 2.52M | 5.45M | 981.33M | 722.54K |
Days Sales Outstanding | 39.78 | 41.31 | 38.88 | 40.35 | 36.13 | 22.43 | 675.68 | 14.56K | 829.88K | 187.74K |
Inventory | 0 | 79.97K | 56.76K | 1.26M | 56.28K | 65.52K | 968 | 0 | 213.41M | 210.93M |
Days Inventory Outstanding | - | 65 | 8.08 | 40.22 | 3.99 | 5.06 | 0.27 | - | 777.95K | 69.06K |
Other Current Assets | 2K | 0 | 0 | 0 | 0 | 198.32K | 176.35K | 542.95K | 59.66M | 1.02B |
Total Non-Current Assets | 10K | 761.51K | 1.77M | 571.4K | 1.39M | 1.62M | 9.78M | 98.55M | 76.26B | 75.89B |
Property, Plant & Equipment | 0 | 15.01K | 932.7K | 549.77K | 1.33M | 1.12M | 198.72K | 218.93K | 38.86M | 24.69M |
Fixed Asset Turnover | - | 255.35x | 7.97x | 31.14x | 7.43x | 9.18x | 6.86x | 0.62x | 0.01x | 0.03x |
Goodwill | 0 | 725.97K | 725.97K | 0 | 0 | 0 | 0 | 21.37M | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 8.96M | 76.4M | 70.97B | 70.52B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.47M |
Other Non-Current Assets | 10K | 20.53K | 109.87K | 21.64K | 60.14K | 499.87K | 618.45K | 22.04K | 5.25B | 5.34B |
Total Assets | 617.48K▲ 0% | 2.23M▲ 260.8% | 5.57M▲ 150.1% | 9.79M▲ 75.8% | 5.77M▼ 41.1% | 3.71M▼ 35.7% | 12.53M▲ 237.8% | 104.85M▲ 736.6% | 84.18B▲ 80181.6% | 80.66B▲ 0% |
Asset Turnover | 4.75x | 1.72x | 1.33x | 1.75x | 1.72x | 2.76x | 0.11x | 0.00x | 0.00x | 0.00x |
Asset Growth % | 83.16% | 260.76% | 150.11% | 75.76% | -41.12% | -35.66% | 237.81% | 736.63% | 80181.62% | 156534.65% |
Total Current Liabilities | 525.36K | 860.37K | 520.82K | 842.24K | 926.03K | 2.15M | 11.56M | 7.91M | 2.74B | 2.8B |
Accounts Payable | 106.08K | 400.54K | 334.61K | 256.83K | 477.03K | 527.98K | 1.46M | 2.9M | 1.44B | 1.4M |
Days Payables Outstanding | - | 325.57 | 47.61 | 8.21 | 33.85 | 40.74 | 406.15 | 8.1K | 1000K | 236.08K |
Short-Term Debt | 262.31K | 321.5K | 0 | 225K | 0 | 166.67K | 6.53M | 2.7M | 24.14M | 10M |
Deferred Revenue (Current) | 0 | 0 | 0 | 10K | 0 | 5.13K | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 916.52K | 3.37M | 930.72K | 1.27B | 2.79B |
Current Ratio | 1.16x | 1.70x | 7.30x | 10.95x | 4.72x | 0.98x | 0.24x | 0.80x | 2.89x | 1.70x |
Quick Ratio | 1.16x | 1.61x | 7.19x | 9.46x | 4.66x | 0.94x | 0.24x | 0.80x | 2.82x | 1.63x |
Cash Conversion Cycle | - | -219.27 | -0.65 | 72.35 | 6.27 | -13.25 | 269.81 | - | -1000K | 20.71K |
Total Non-Current Liabilities | 404.05K | 522.55K | 910.46K | 271.31K | 1.07M | 1.22M | 434.2K | 17.87M | 11.32B | 11.04B |
Long-Term Debt | 404.05K | 522.55K | 225K | 0 | 0 | 333.33K | 25K | 612.27K | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 685.46K | 271.31K | 1.07M | 887.03K | 176.91K | 156.47K | 0 | 2.55K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.52M | 11.04B | 22.1B |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 232.3K | 3.58M | 285M | 0 |
Total Liabilities | 929.41K | 1.38M | 1.43M | 1.11M | 2M | 3.37M | 11.99M | 25.78M | 14.06B | 13.84B |
Total Debt | 666.36K | 844.05K | 997.81K | 627.46K | 1.25M | 1.58M | 6.76M | 3.53M | 24.14M | 10M |
Net Debt | 482.45K | -25.5K | -1.87M | -5.29M | -1.87M | 489.01K | 6.76M | 3.22M | 23.83M | -3.53B |
Debt / Equity | - | 1.00x | 0.24x | 0.07x | 0.33x | 4.62x | 12.47x | 0.04x | 0.00x | 0.00x |
Debt / EBITDA | 1.49x | 12.68x | 4.54x | - | - | - | - | - | - | -0.69x |
Net Debt / EBITDA | 1.08x | -0.38x | -8.52x | - | - | - | - | - | - | 243.90x |
Interest Coverage | 2.84x | 1.16x | -4.34x | -85.29x | -224.34x | -6.15x | -6.42x | -13.06x | -9.66x | -11.75x |
Total Equity | -311.93K▲ 0% | 844.67K▲ 370.8% | 4.14M▲ 390.2% | 8.68M▲ 109.6% | 3.77M▼ 56.6% | 342.87K▼ 90.9% | 542.35K▲ 58.2% | 79.07M▲ 14479.5% | 70.12B▲ 88579.0% | 66.82B▲ 0% |
Equity Growth % | 72.83% | 370.79% | 390.16% | 109.63% | -56.56% | -90.91% | 58.18% | 14479.46% | 88579.02% | 171365.72% |
Book Value per Share | -0.82 | 2.18 | 10.47 | 16.90 | 6.95 | 0.61 | 0.23 | 21.64 | 456.89 | 164.46 |
Total Shareholders' Equity | -311.93K | 844.67K | 4.14M | 8.68M | 3.77M | 763.14K | 542.35K | 79.07M | 70.12B | 66.82B |
Common Stock | 320 | 55 | 65 | 81 | 82 | 6 | 9 | 87 | 406K | 406K |
Retained Earnings | -8.12M | -8.11M | -8.4M | -10.93M | -16.25M | -19.72M | -33.25M | -39.04M | -80.55B | -83.95B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | -420.27K | 0 | 0 | 0 | 0 |
SCNX Cash Flow Statement
Scienture Holdings, Inc. (SCNX) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 171.67K | 273.39K | 141.78K | -2.21M | -2.57M | -1.56M | -2.23M | -14.27M | -13.38B | -2.93B |
Operating CF Margin % | 5.86% | 7.13% | 1.91% | -12.93% | -25.95% | -15.26% | -163.16% | -10439.79% | -3100603.09% | - |
Operating CF Growth % | 113.07% | 59.25% | -48.14% | -1662.18% | -15.87% | 39.03% | -42.22% | -541.08% | -93711.83% | -98827.38% |
Net Income | 288.98K | 9.04K | -284.43K | -2.54M | -5.32M | -2.4M | -8.48M | -18.24M | -41.51B | -41.85M |
Depreciation & Amortization | 0 | 0 | 94.73K | 102.52K | 138.91K | 194.7K | 1.05M | 53.36K | 455.85M | 454.82M |
Stock-Based Compensation | 0 | 0 | 0 | 1.36M | 181.16K | 254.11K | 257.77K | 0 | 2.07B | 102.57M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 385.54K | 179.69K | 999.33K | 2.46M | 1.34M | 132.38K | -563.18K | 6.53M | 25.61B | -41.66M |
Working Capital Changes | -502.85K | 84.65K | -667.86K | -3.6M | 1.08M | 257.58K | 5.51M | -2.6M | -3.07M | -2.7M |
Change in Receivables | -20.35K | -1.53K | -369.92K | -23.53K | 298.09K | -505.32K | -548.71K | -2.93M | -800.69K | -894.28K |
Change in Inventory | 0 | -3.81K | 23.2K | -2.42M | 825.13K | -51.74K | 4.23M | 968 | -213.41K | -210.93K |
Change in Payables | -98.21K | 95.15K | -148.66K | -33.19K | 220.2K | 199.83K | 1.61M | 448.57K | -1.57M | -1.49M |
Cash from Investing | 0 | -265.28K | -332.25K | -37.51K | -22.6K | -427.85K | -275.72K | 27.55M | 0 | 0 |
Capital Expenditures | 0 | -15.01K | -82.25K | -37.51K | -22.6K | -450.85K | 0 | -12K | 0 | 0 |
CapEx % of Revenue | - | 0.39% | 1.11% | 0.22% | 0.23% | 4.4% | 0% | 8.78% | - | 0% |
Acquisitions | 0 | -250.27K | -250K | 0 | 0 | 0 | -344.45K | 132.98K | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 23K | 68.74K | 27.43M | 0 | 0 |
Cash from Financing | -2.44K | 677.54K | 2.19M | 5.3M | -208.18K | -35.17K | 1.41M | -12.98M | 19.73B | -184.96M |
Debt Issued (Net) | -252.69K | -122.46K | -262.55K | 0 | -225K | 0 | 250K | 3.1M | -6.16M | -6.26M |
Equity Issued (Net) | 250K | 800K | 2.46M | 5.99M | 0 | 130.92K | 518.02K | 26.41K | 26.29M | 21.7M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.86M | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 250 | 0 | 166 | -694.25K | 16.82K | -166.09K | 638.31K | -1.25M | 19.71B | -200.4M |
Net Change in Cash | 169.24K▲ 0% | 685.64K▲ 305.1% | 2M▲ 192.0% | 3.05M▲ 52.2% | -2.8M▼ 191.8% | -2.03M▲ 27.5% | -1.09M▲ 46.0% | 307.78K▲ 128.1% | 6.35B▲ 2064319.6% | -3.11B▲ 0% |
Free Cash Flow | 171.67K▲ 0% | 258.38K▲ 50.5% | 59.52K▼ 77.0% | -2.25M▼ 3883.9% | -2.59M▼ 14.9% | -1.56M▲ 39.6% | -2.23M▼ 42.2% | -14.28M▼ 541.6% | -13.38B▼ 93633.0% | -2.93B▲ 0% |
FCF Margin % | 5.86% | 6.74% | 0.8% | -13.15% | -26.18% | -15.26% | -163.16% | -10448.57% | -3100603.09% | -613319.12% |
FCF Growth % | 113.07% | 50.51% | -76.96% | -3883.9% | -14.94% | 39.56% | -42.21% | -541.62% | -93632.98% | -41490.97% |
FCF per Share | 0.45 | 0.67 | 0.15 | -4.38 | -4.77 | -2.77 | -0.93 | -3.91 | -87.20 | -7.21 |
FCF Conversion (FCF/Net Income) | 0.59x | 30.25x | -0.50x | 0.87x | 0.48x | 0.45x | 0.12x | -1.57x | 322.37x | 70.00x |
Interest Paid | 71.21K | 36.97K | 98.46K | 29.44K | 28.34K | 336.21K | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCNX Key Ratios
Scienture Holdings, Inc. (SCNX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | 3.39% | -11.41% | -39.57% | -85.4% | -168.83% | -4031.44% | 22.77% | -0.12% | -0.12% |
Return on Invested Capital (ROIC) | - | -13.28% | 6.09% | -66.51% | -150.26% | -160.34% | -81.03% | -24.61% | -0.03% | -0.03% |
Gross Margin | 100% | 88.28% | 65.5% | 33.33% | 47.99% | 53.85% | 3.6% | 4.39% | 76.8% | -17.45% |
Net Margin | 9.86% | 0.24% | -3.82% | -14.81% | -53.75% | -33.87% | -1308.34% | 6634.66% | -9618.03% | -8761.28% |
Debt / Equity | - | 1.00x | 0.24x | 0.07x | 0.33x | 4.62x | 12.47x | 0.04x | 0.00x | 0.00x |
Interest Coverage | 2.84x | 1.16x | -4.34x | -85.29x | -224.34x | -6.15x | -6.42x | -13.06x | -9.66x | -11.75x |
FCF Conversion | 0.59x | 30.25x | -0.50x | 0.87x | 0.48x | 0.45x | 0.12x | -1.57x | 322.37x | 70.00x |
Revenue Growth | 18.11% | 30.72% | 94.07% | 130.26% | -42.24% | 3.65% | -86.69% | -89.98% | 215.87% | 225.17% |
Related:SCNX Dividend History·SCNX Revenue History·SCNX Price History·SCNX P/E History·SCNX Financial Ratios·SCNX Institutional Holders
SCNX SEC Filings & Documents
Scienture Holdings, Inc. (SCNX) SEC filings — annual & quarterly reports (10-K, 10-Q)
SCNX Frequently Asked Questions
Scienture Holdings, Inc. (SCNX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Scienture Holdings, Inc. (SCNX) reported $0.5M in revenue for fiscal year 2025.
Scienture Holdings, Inc. (SCNX) grew revenue by 215.9% over the past year. This is strong growth.
Scienture Holdings, Inc. (SCNX) reported a net loss of $41.9M for fiscal year 2025.
Dividend & Returns
Scienture Holdings, Inc. (SCNX) has a return on equity (ROE) of -0.1%. Negative ROE indicates the company is unprofitable.
Scienture Holdings, Inc. (SCNX) had negative free cash flow of $2.93B in fiscal year 2025, likely due to heavy capital investments.